Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Spectranetics Corp.

Aug 2008
The ThromboAblation in Acute Myo-cardial Infarction trial has begun enrolling participants. The 200-patient randomized trial, to be performed by Spectranetics Corp. of Colorado Springs, Colo., will test the usefulness of excimer lasers in treating people with a large thrombus burden presenting with ST wave elevation myocardial infarction.

Biophotonicsexcimer lasersNews & FeaturesSpectranetics Corp.lasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!